Display Settings:

Format

Send to:

Choose Destination

    Science. 1989 Dec 1;246(4934):1149-52.

    Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

    Miller M, Schneider J, Sathyanarayana BK, Toth MV, Marshall GR, Clawson L, Selk L, Kent SB, Wlodawer A.

    NCI-Frederick Cancer Research Facility, BRI-Basic Research Program, MD 21701.

    The structure of a complex between a peptide inhibitor with the sequence N-acetyl-Thr-Ile-Nle-psi[CH2-NH]-Nle-Gln-Arg.amide (Nle, norleucine) with chemically synthesized HIV-1 (human immunodeficiency virus 1) protease was determined at 2.3 A resolution (R factor of 0.176). Despite the symmetric nature of the unliganded enzyme, the asymmetric inhibitor lies in a single orientation and makes extensive interactions at the interface between the two subunits of the homodimeric protein. Compared with the unliganded enzyme, the protein molecule underwent substantial changes, particularly in an extended region corresponding to the "flaps" (residues 35 to 57 in each chain), where backbone movements as large as 7 A are observed.

    PMID: 2686029 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Structures reported by this article